Table of Contents Global Cancer Immunotherapy Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Cancer Immunotherapy Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Cancer Immunotherapy Segment by Type 1.2.1 Monoclonal Antibodies 1.2.2 Immune Checkpoint Inhibitors 1.2.3 Immune System Modulators 1.2.4 Cancer Vaccines 1.3 Market Analysis by Application 1.3.1 Lung Cancer 1.3.2 Breast Cancer 1.3.3 Colorectal Cancer 1.3.4 Melanoma 1.3.5 Prostate Cancer 1.3.6 Others 1.4 Overview of Global Cancer Immunotherapy Market 1.4.1 Global Cancer Immunotherapy Revenue (2015-2025) 1.4.2 Global Cancer Immunotherapy Production and Capacity (2015-2025) 1.4.3 North America Cancer Immunotherapy Status and Prospect (2015-2025) 1.4.4 Europe Cancer Immunotherapy Status and Prospect (2015-2025) 1.4.5 Japan Cancer Immunotherapy Status and Prospect (2014-2025) 1.4.6 China Cancer Immunotherapy Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Cancer Immunotherapy Industry Impact 1.6.1 How the Covid-19 is Affecting the Cancer Immunotherapy Industry 1.6.2 Cancer Immunotherapy Business Impact Assessment - Covid-19 1.6.3 Market Trends and Cancer Immunotherapy Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Cancer Immunotherapy Market Competition by Manufacturer 2.1 Global Cancer Immunotherapy Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Cancer Immunotherapy Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Cancer Immunotherapy Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Cancer Immunotherapy Manufacturer Market Share 2.5 Top 10 Cancer Immunotherapy Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Cancer Immunotherapy Market 2.7 Key Manufacturers Cancer Immunotherapy Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Cancer Immunotherapy Industry Key Manufacturers 3.1 Amgen 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Amgen Cancer Immunotherapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Amgen News 3.2 AstraZeneca 3.2.1 Company Details 3.2.2 Product Information 3.2.3 AstraZeneca Cancer Immunotherapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 AstraZeneca News 3.3 Roche 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Roche Cancer Immunotherapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Roche News 3.4 Bayer 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Bayer Cancer Immunotherapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Bayer News 3.5 Bristol-Myers Squibb 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Bristol-Myers Squibb Cancer Immunotherapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Bristol-Myers Squibb News 3.6 Eli Lilly 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Eli Lilly Cancer Immunotherapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Eli Lilly News 3.7 Merck 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Merck Cancer Immunotherapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Merck News 3.8 Novartis 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Novartis Cancer Immunotherapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Novartis News 3.9 Pfizer 3.9.1 Company Details 3.9.2 Product Information 3.9.3 Pfizer Cancer Immunotherapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.9.4 Main Business Overview 3.9.5 Pfizer News 4 Global Cancer Immunotherapy Market Size Categorized by Regions (2015-2020) 4.1 Global Cancer Immunotherapy Sales Market Share by Region 4.2 Global Cancer Immunotherapy Revenue Market Share by Region (2015-2019) 4.3 Global Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Cancer Immunotherapy Market Size Detail 4.4.1 North America Cancer Immunotherapy Sales Growth Rate (2015-2020) 4.4.2 North America Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Cancer Immunotherapy Market Size Detail 4.5.1 Europe Cancer Immunotherapy Sales Growth Rate (2015-2020) 4.5.2 Europe Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Cancer Immunotherapy Market Size Detail 4.6.1 Japan Cancer Immunotherapy Sales Growth Rate (2015-2020) 4.6.2 Japan Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Cancer Immunotherapy Market Size Detail 4.7.1 China Cancer Immunotherapy Sales Growth Rate (2015-2020) 4.7.2 China Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Cancer Immunotherapy Market Segment by Type 5.1 Global Cancer Immunotherapy Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Cancer Immunotherapy Sales and Market Share by Type (2015-2020) 5.1.2 Global Cancer Immunotherapy Revenue and Market Share by Type (2015-2020) 5.2 Monoclonal Antibodies Sales Growth Rate and Price 5.2.1 Global Monoclonal Antibodies Sales Growth Rate (2015-2020) 5.2.2 Global Monoclonal Antibodies Price (2015-2020) 5.3 Immune Checkpoint Inhibitors Sales Growth Rate and Price 5.3.1 Global Immune Checkpoint Inhibitors Sales Growth Rate (2015-2020) 5.3.2 Global Immune Checkpoint Inhibitors Price (2015-2020) 5.4 Immune System Modulators Sales Growth Rate and Price 5.4.1 Global Immune System Modulators Sales Growth Rate (2015-2020) 5.4.2 Global Immune System Modulators Price (2015-2020) 5.5 Cancer Vaccines Sales Growth Rate and Price 5.5.1 Global Cancer Vaccines Sales Growth Rate (2015-2020) 5.5.2 Global Cancer Vaccines Price (2015-2020) 6 Global Cancer Immunotherapy Market Segment by Application 6.1 Global Cancer Immunotherapy Sales Market Share by Application (2015-2020) 6.2 Lung Cancer Sales Growth Rate (2015-2020) 6.3 Breast Cancer Sales Growth Rate (2015-2020) 6.4 Colorectal Cancer Sales Growth Rate (2015-2020) 6.5 Melanoma Sales Growth Rate (2015-2020) 6.6 Prostate Cancer Sales Growth Rate (2015-2020) 6.7 Others Sales Growth Rate (2015-2020) 7 Cancer Immunotherapy Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Cancer Immunotherapy Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Cancer Immunotherapy Market Forecast 8.1 Global Cancer Immunotherapy Sales, Revenue Forecast 8.1.1 Global Cancer Immunotherapy Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Cancer Immunotherapy Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Cancer Immunotherapy Price and Trend Forecast (2020-2025) 8.2 Global Cancer Immunotherapy Sales Forecast by Region (2020-2025) 8.2.1 North America Cancer Immunotherapy Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Cancer Immunotherapy Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Cancer Immunotherapy Production, Revenue Forecast (2020-2025) 8.2.4 China Cancer Immunotherapy Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Cancer Immunotherapy Picture Table Global Cancer Immunotherapy Sales by Type Figure Global Sales Market Share of Cancer Immunotherapy by Product Type in 2019 Table Breakdown of Cancer Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3) Figure Cancer Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Monoclonal Antibodies Picture Figure Immune Checkpoint Inhibitors Picture Figure Immune System Modulators Picture Figure Cancer Vaccines Picture Table Global Cancer Immunotherapy Sales by Application Figure Global Cancer Immunotherapy Sales Market Share by Application in 2019 Figure Lung Cancer Picture Figure Breast Cancer Picture Figure Colorectal Cancer Picture Figure Melanoma Picture Figure Prostate Cancer Picture Figure Others Picture Table Cancer Immunotherapy Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Cancer Immunotherapy Revenue (Million US$) (2015-2025) Figure Global Cancer Immunotherapy Production (K Units) (2015-2025) Figure North America Cancer Immunotherapy Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Cancer Immunotherapy Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Cancer Immunotherapy Revenue (Million US$) Growth Rate (2014-2025) Figure China Cancer Immunotherapy Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Cancer Immunotherapy Sales by Manufacturer (2018-2020) Figure Global Cancer Immunotherapy Sales Market Share by Manufacturer in 2019 Table Global Cancer Immunotherapy Revenue by Manufacturer (2018-2020) Figure Global Cancer Immunotherapy Revenue Market Share by Manufacturer in 2019 Table Global Cancer Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Cancer Immunotherapy Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Cancer Immunotherapy Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Cancer Immunotherapy Market Table Key Manufacturers Cancer Immunotherapy Product Type Table Mergers & Acquisitions Planning Table Amgen Company Profile Figure Cancer Immunotherapy Product Picture and Specifications of Amgen Table Cancer Immunotherapy Production, Price, Revenue and Gross Margin of 2018-2020 Figure Amgen Cancer Immunotherapy Market Share (2018-2020) Table Amgen Main Business Table Amgen Recent Development Table AstraZeneca Company Profile Figure Cancer Immunotherapy Product Picture and Specifications of AstraZeneca Table Cancer Immunotherapy Production, Price, Revenue and Gross Margin of 2018-2020 Figure AstraZeneca Cancer Immunotherapy Market Share (2018-2020) Table AstraZeneca Main Business Table AstraZeneca Recent Development Table Roche Company Profile Figure Cancer Immunotherapy Product Picture and Specifications of Roche Table Cancer Immunotherapy Production, Price, Revenue and Gross Margin of 2018-2020 Figure Roche Cancer Immunotherapy Market Share (2018-2020) Table Roche Main Business Table Roche Recent Development Table Bayer Company Profile Figure Cancer Immunotherapy Product Picture and Specifications of Bayer Table Cancer Immunotherapy Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bayer Cancer Immunotherapy Market Share (2018-2020) Table Bayer Main Business Table Bayer Recent Development Table Bristol-Myers Squibb Company Profile Figure Cancer Immunotherapy Product Picture and Specifications of Bristol-Myers Squibb Table Cancer Immunotherapy Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bristol-Myers Squibb Cancer Immunotherapy Market Share (2018-2020) Table Bristol-Myers Squibb Main Business Table Bristol-Myers Squibb Recent Development Table Eli Lilly Company Profile Figure Cancer Immunotherapy Product Picture and Specifications of Eli Lilly Table Cancer Immunotherapy Production, Price, Revenue and Gross Margin of 2018-2020 Figure Eli Lilly Cancer Immunotherapy Market Share (2018-2020) Table Eli Lilly Main Business Table Eli Lilly Recent Development Table Merck Company Profile Figure Cancer Immunotherapy Product Picture and Specifications of Merck Table Cancer Immunotherapy Production, Price, Revenue and Gross Margin of 2018-2020 Figure Merck Cancer Immunotherapy Market Share (2018-2020) Table Merck Main Business Table Merck Recent Development Table Novartis Company Profile Figure Cancer Immunotherapy Product Picture and Specifications of Novartis Table Cancer Immunotherapy Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis Cancer Immunotherapy Market Share (2018-2020) Table Novartis Main Business Table Novartis Recent Development Table Pfizer Company Profile Figure Cancer Immunotherapy Product Picture and Specifications of Pfizer Table Cancer Immunotherapy Production, Price, Revenue and Gross Margin of 2018-2020 Figure Pfizer Cancer Immunotherapy Market Share (2018-2020) Table Pfizer Main Business Table Pfizer Recent Development Table Global Cancer Immunotherapy Sales (K Units) by Region (2015-2020) Table Global Cancer Immunotherapy Sales Market Share by Region (2015-2019) Figure Global Cancer Immunotherapy Sales Market Share by Region (2015-2019) Figure Global Cancer Immunotherapy Sales Market Share by Region in 2018 Table Global Cancer Immunotherapy Revenue (Million US$) by Region (2015-2020) Table Global Cancer Immunotherapy Revenue Market Share by Region (2015-2020) Figure Global Cancer Immunotherapy Revenue Market Share by Region (2015-2020) Figure Global Cancer Immunotherapy Revenue Market Share by Region in 2019 Table Global Cancer Immunotherapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Cancer Immunotherapy Sales (K Units) Growth Rate (2015-2020) Figure Europe Cancer Immunotherapy Sales (K Units) Growth Rate (2015-2020) Table Europe Cancer Immunotherapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Cancer Immunotherapy Sales (K Units) Growth Rate (2015-2020) Table Japan Cancer Immunotherapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Cancer Immunotherapy Sales (K Units) Growth Rate (2015-2020) Table China Cancer Immunotherapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Cancer Immunotherapy Sales by Type (2015-2020) Table Global Cancer Immunotherapy Sales Market Share by Type (2015-2020) Figure Global Cancer Immunotherapy Sales Market Share by Type in 2019 Table Global Cancer Immunotherapy Revenue by Type (2015-2020) Table Global Cancer Immunotherapy Revenue Market Share by Type (2015-2020) Figure Global Cancer Immunotherapy Revenue Market Share by Type in 2019 Figure Global Monoclonal Antibodies Sales Growth Rate (2015-2025) Figure Global Monoclonal Antibodies Price (2015-2020) Figure Global Immune Checkpoint Inhibitors Sales Growth Rate (2015-2025) Figure Global Immune Checkpoint Inhibitors Price (2015-2020) Figure Global Immune System Modulators Sales Growth Rate (2015-2025) Figure Global Immune System Modulators Price (2015-2020) Figure Global Cancer Vaccines Sales Growth Rate (2015-2025) Figure Global Cancer Vaccines Price (2015-2020) Table Global Cancer Immunotherapy Sales Market Share by Application (2015-2020) Figure Global Cancer Immunotherapy Sales Market Share by Application in 2019 Figure Global Lung Cancer Sales Growth Rate (2015-2025) Figure Global Breast Cancer Sales Growth Rate (2015-2025) Figure Global Colorectal Cancer Sales Growth Rate (2015-2025) Figure Global Melanoma Sales Growth Rate (2015-2025) Figure Global Prostate Cancer Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Cancer Immunotherapy Table Key Players of Downstream Markets Figure Sales Channel Figure Global Cancer Immunotherapy Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Cancer Immunotherapy Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Cancer Immunotherapy Price and Trend Forecast (2020-2025) Table Global Cancer Immunotherapy Sales (K Units) Forecast by Region (2020-2025) Figure Global Cancer Immunotherapy Production Market Share Forecast by Region (2020-2025) Figure North America Cancer Immunotherapy Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Cancer Immunotherapy Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Cancer Immunotherapy Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Cancer Immunotherapy Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Cancer Immunotherapy Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Cancer Immunotherapy Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Cancer Immunotherapy Production (K Units) Growth Rate Forecast (2020-2025) Figure China Cancer Immunotherapy Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Amgen AstraZeneca Roche Bayer Bristol-Myers Squibb Eli Lilly Merck